…stments across all sectors. He is currently on the boards of directors of AwarePoint, Oxford Immunotech (NASDAQ: OXFP), iRhythm Technologies, Kit Check, TigerText and XDx, while maintaining board observer status with Labcyte. Vijay was previously on the boards of Advanced Cell Di...
Results for “iRhythm Technologies”
Search across the indexed text of every released document.
Names that match “iRhythm Technologies”
223 documents found
National Pub date: February 19, 2019 Title: DEEP THINKING Subtitle: Twenty-Five Ways of Looking at AI By: John Brockman Length: 90,000 words Headline: Science world luminary John Brockman assembles twenty-five of the most important scientific minds, people who have been thinking...
INTELLECTUAL JAZZ DAVID AGUS DAN ARIELY KEITH BLACK DAVID BLAINE MIKE BLOCK ADAM B LY SCOTT BOLTON DAVID BROOKS MARK CUBAN ANTONIO DAMASIO JACK DANGERMOND DAVE GALLO FRANK GEHRY MATT GROENING HERBIE HANCOCK DANNY HILLIS BJARKE INGELS QUINCY JONES MARY JORDAN JON KAMEN JEFFREY KA...
The Seventh Sense Power, Fortune and Survival in the Age of Networks Joshua Cooper Ramo 1 . Part One: The Nature of Our Age In which the revolutionary character of our era is explained. The need for a new instinct is introduced. The historical stakes are weighed. Chapter 1: The...
Internet & Society: The Technologies and Politics of Control Professor Jonathan Zittrain co-taught with Professor Joi Ito, Director of the MIT Media Lab Harvard Law School Winter 2017 Mon-Fri 10:30am-noon; 12:45pm-2pm Milstein West AB Syllabus I. Course Description This course of...
Available Third Party Reports and Documentation The following summarizes available third party reports that are posted within the online due diligence site: ALTA Survey Wallace Morris Surveying, dated May 2013 Title Report by First American, dated July 2015 Tax bills 2014 — 2...
November 21, 2011 Topic: The quixotic search for energy solutions Another Don Quixote Thanksgiving. Every year at Thanksgiving 1 , we look in-depth at an issue that affects markets and portfolios. Last year, we examined the unraveling situation in Europe. Unfortunately, most con...
ACKRELL CAPITAL CHAPTER VII Capital Markets for Cannabis Companies Over The Counter (Market Value Greater than $25 million) Enterprise Value (EV) LTM Revenue LTM LTM EV Multiples EBITDA Revenue EBITDA ($U.S. millions, except stock price) Stock % Below Price 52-Week Mark...
these diseases further from what has historically been a death sentence into a chronic, treatable condition. As this happens, huge markets will be created for entirely new biopharmaceutical products. While cancer is the leading disease area, this pace of dramatic scientific and t...
Top 10 US Ideas Quarterly Q1 Top 10 Ideas Strategy Equity | 03 January 2017 Corrected Top 10 US Ideas – 1Q17 The backdrop for risk assets has changed dramatically over the past year. As Michael Hartnett pointed out, 2016 saw global interest rates fall to 5,000-year lows and the...
113 Fla. Dec. 14, 2010), ECF No. 3, available at http://wwwjustice.gov/ criminal/fraud/fcpa/cases/granados-jorge/ 12-21- 10granados-indict.pdf. 194 See Deferred Pros. Agreement, United States v. Snamprogetti, supra note 60, ECF No. 3, available at hetp://www.justice.gov/criminal...
JOHN MAZZIOTTA Dr. John Mazziotta is Chair of the Department of Neurology, David Geffen School of Medicine at UCLA, and Director of the UCLA Ahmanson-Lovelace Brain Mapping Center. After receiving his B.A. and M.A. degrees from Columbia University in 1972, he obtained an M.D....
VI. DEAL SOURCING & INVESTMENT PROCESS The Fund Managers have a proactive approach to deal sourcing, which focuses on both private and public opportunities. The established and proven sourcing activities seek to identify the most compelling healthcare technology investment oppor...
183 technologies. It is unclear how the United Kingdom’s Brexit plan will affect the stated desire of the UK government to ensure that critical technologies do not fall into Chinese hands. For years, the Chinese telecom behemoth Huawei has provided broadband gear and mobile net...
introduces a range of new incentives/ penalties that force market participants to address major cost, efficiency, and quality issues within the healthcare system. The ACA and other healthcare reform initiatives are challenged by dual and somewhat conflicting objectives. They are...